SEGMENTED INFORMATION

9 Months Ended

Sep. 30, 2021

SEGMENTED INFORMATION

NOTE 13 - SEGMENTED INFORMATION

NOTE 13 - SEGMENTED INFORMATION

At September 30, 2021, the Company (“BGLC”) operates in the biochemical industry segment through its two Malaysian subsidiaries, BioNexus Malaysia and Chemrex.

	BioNexus Gene Lab Corp. a Wyoming company
100% owned		100% owned
Bionexus Gene Lab Sdn. Bhd., a Malaysian company		Chemrex Corporation Sdn. Bhd., a Malaysian company

For the quarter ended September 30, 2021, segmented (unaudited) revenue and net profit/(loss) (Currency expressed in United States Dollars (“US$”) are as follows:

	BioNexus Malaysia			Chemrex			BGLC			Total
	Nine months ended September 30, 2021
REVENUE	$	1,504,064		$	8,613,232		$	-		$	10,117,296
COST OF REVENUE		(1,108,817	)		(7,270,208	)		-			(8,379,025	)
GROSS PROFIT		395,247			1,343,024			-			1,738,271
OTHER INCOME		5,335			154,429			-			159,764
OPERATING EXPENSES
General and administrative		(64,255	)		(843,620	)		(135,396	)		(1,043,271	)
FINANCE COSTS		(3,265	)		(5,722	)		-			(8,987	)
PROFIT BEFORE TAX		333,062			648,111			(135,396	)		845,777
Tax expense		(38,068	)		(145,381	)		-			(183,449	)
NET PROFIT/(LOSS)	$	294,994		$	502,730		$	(135,396	)	$	662,328

	BioNexus Malaysia			Chemrex			BGLC			Total
	Nine months ended September 30, 2020
REVENUE	$	30,012		$	7,234,542		$	-		$	7,264,554
COST OF REVENUE		(45,561	)		(5,882,174	)		-			(5,927,735	)
GROSS (LOSS)/PROFIT		(15,549	)		1,352,368			-			1,336,819
OTHER INCOME		10,540			768,910			8			779,458
OPERATING EXPENSES
General and administrative		(67,852	)		(673,211	)		(98,352	)		(839,415	)
FINANCE COSTS		(1,480	)		(5,282	)		-			(6,762	)
(LOSS)/PROFIT BEFORE TAX		(74,341	)		1,442,785			(98,344	)		1,270,100
Tax expense		(1,839	)		-			-			(1,839	)
NET (LOSS)/PROFIT	$	(76,180	)	$	1,442,785		$	(98,344	)	$	1,268,261

	As of September 30, 2021 and December 31, 2020
	Total Assets				Total Liabilities
	2021		2020		2021		2020
BGLC & Bionexus	$	1,871,430	$	1,107,048	$	807,903	$	169,325
Chemrex		7,893,574		9,008,245		1,905,495		3,283,814
TOTAL		9,765,004		10,115,293		2,713,398		3,453,139